Editas Medicine (NASDAQ:EDIT – Get Free Report) is one of 844 publicly-traded companies in the “Biotechnology” industry, but how does it compare to its rivals? We will compare Editas Medicine to similar companies based on the strength of its valuation, analyst recommendations, profitability, risk, institutional ownership, dividends and earnings. Insider & Institutional Ownership 71.9% of […]

Health Catalyst (NASDAQ:HCAT – Get Free Report) is one of 93 public companies in the “Healthcare Technology” industry, but how does it weigh in compared to its competitors? We will compare Health Catalyst to related companies based on the strength of its earnings, profitability, institutional ownership, analyst recommendations, valuation, risk and dividends. Institutional & Insider […]